| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $5,288,921 ) |
| | 2025 | 2025 | ENSYSCE BIOSCIENCES, INC. | 7946 IVANHOE AVE | LA JOLLA | CA | 92037-4517 | SAN DIEGO | USA | U01DA059791 | PF614-MPAR: clinical development of opioid with oral overdose protection | 002 | 2 | NIH | 6/11/2025 | $5,288,921 |
| | 2025 | 2024 | ENSYSCE BIOSCIENCES, INC. | 7946 IVANHOE AVE | LA JOLLA | CA | 92037-4517 | SAN DIEGO | USA | U01DA059791 | PF614-MPAR: clinical development of opioid with oral overdose protection | 000 | 1 | NIH | 11/8/2024 | $0 |
| | 2025 | 2024 | ENSYSCE BIOSCIENCES, INC. | 7946 IVANHOE AVE | LA JOLLA | CA | 92037-4517 | SAN DIEGO | USA | U01DA059791 | PF614-MPAR: clinical development of opioid with oral overdose protection | 001 | 1 | NIH | 5/30/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $4,572,695 ) |
| | 2024 | 2024 | ENSYSCE BIOSCIENCES, INC. | 7946 IVANHOE AVE | LA JOLLA | CA | 92037-4517 | SAN DIEGO | USA | U01DA059791 | PF614-MPAR: clinical development of opioid with oral overdose protection | 000 | 1 | NIH | 8/26/2024 | $4,572,695 |
|
|
